Australia · Delayed Price · Currency is AUD Vitasora Health Statistics
Total Valuation
Vitasora Health has a market cap or net worth of AUD 32.77 million. The enterprise value is 29.68 million.
| Market Cap | 32.77M |
| Enterprise Value | 29.68M |
Important Dates
The next estimated earnings date is Friday, September 11, 2026.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vitasora Health has 2.34 billion shares outstanding. The number of shares has increased by 31.80% in one year.
| Current Share Class | 2.34B |
| Shares Outstanding | 2.34B |
| Shares Change (YoY) | +31.80% |
| Shares Change (QoQ) | +11.43% |
| Owned by Insiders (%) | 17.84% |
| Owned by Institutions (%) | 7.53% |
| Float | 1.68B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.77 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 6.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.90
| Current Ratio | 2.90 |
| Quick Ratio | 1.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.25% and return on invested capital (ROIC) is -43.83%.
| Return on Equity (ROE) | -70.25% |
| Return on Assets (ROA) | -36.19% |
| Return on Invested Capital (ROIC) | -43.83% |
| Return on Capital Employed (ROCE) | -65.48% |
| Weighted Average Cost of Capital (WACC) | 2.34% |
| Revenue Per Employee | 161,330 |
| Profits Per Employee | -353,671 |
| Employee Count | 30 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 0.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.15% in the last 52 weeks. The beta is -0.35, so Vitasora Health's price volatility has been lower than the market average.
| Beta (5Y) | -0.35 |
| 52-Week Price Change | -46.15% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 52.50 |
| Average Volume (20 Days) | 1,900,557 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitasora Health had revenue of AUD 4.84 million and -10.61 million in losses. Loss per share was -0.01.
| Revenue | 4.84M |
| Gross Profit | 4.26M |
| Operating Income | -10.61M |
| Pretax Income | -10.61M |
| Net Income | -10.61M |
| EBITDA | -9.36M |
| EBIT | -10.61M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.08 million in cash and no debt, with a net cash position of 3.08 million or 0.00 per share.
| Cash & Cash Equivalents | 3.08M |
| Total Debt | n/a |
| Net Cash | 3.08M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 16.13M |
| Book Value Per Share | 0.01 |
| Working Capital | 5.00M |
Cash Flow
| Operating Cash Flow | -10.00M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.25M |
| Net Borrowing | n/a |
| Free Cash Flow | -10.00M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 88.02%, with operating and profit margins of -219.22% and -219.22%.
| Gross Margin | 88.02% |
| Operating Margin | -219.22% |
| Pretax Margin | -219.22% |
| Profit Margin | -219.22% |
| EBITDA Margin | -193.34% |
| EBIT Margin | -219.22% |
| FCF Margin | n/a |
Dividends & Yields
Vitasora Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.80% |
| Shareholder Yield | -31.80% |
| Earnings Yield | -32.38% |
| FCF Yield | -30.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 31, 2012. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jul 31, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
Vitasora Health has an Altman Z-Score of -3.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.97 |
| Piotroski F-Score | 2 |